Advanced search
Publication Cover
RNA Biology Volume 14, 2017 - Issue 3
Submit an article Journal homepage
2,696
Views
62
CrossRef citations to date
0
Altmetric
Research Paper

Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells

Laure BidouUniversité Pierre et Marie Curie, Paris, France;Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ Paris Sud, Université Paris-Saclay, Gif sur Yvette cedex, France
,
Olivier BugaudInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ Paris Sud, Université Paris-Saclay, Gif sur Yvette cedex, France
,
Valery BelakhovEdith and Joseph Fischer Enzyme Inhibitors Laboratory, Schulich Faculty of Chemistry Technion IIT, Haifa, Israel
,
Timor BaasovEdith and Joseph Fischer Enzyme Inhibitors Laboratory, Schulich Faculty of Chemistry Technion IIT, Haifa, Israel
&
Olivier NamyInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ Paris Sud, Université Paris-Saclay, Gif sur Yvette cedex, FranceCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-1143-5961
ORCID Icon
Pages 378-388 | Received 14 Oct 2016, Accepted 16 Jan 2017, Published online: 23 Feb 2017

Citations (62)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Shiyuan Han, Zimu Zhang, Wenbin Ma, Jun Gao & Yongning Li. (2023) Nucleotide‐Binding Oligomerization Domain (NOD)-Like Receptor Subfamily C (NLRC) as a Prognostic Biomarker for Glioblastoma Multiforme Linked to Tumor Microenvironment: A Bioinformatics, Immunohistochemistry, and Machine Learning-Based Study. Journal of Inflammation Research 16, pages 523-537.
Read now
Eitan Kerem. (2020) ELX-02: an investigational read-through agent for the treatment of nonsense mutation-related genetic disease. Expert Opinion on Investigational Drugs 29:12, pages 1347-1354.
Read now
Silvia Lombardi, Mattia Ferrarese, Saverio Marchi, Paolo Pinton, Mirko Pinotti, Francesco Bernardi & Alessio Branchini. (2020) Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants. RNA Biology 17:2, pages 254-263.
Read now

Articles from other publishers (59)

Jianhao Zhan, Jisheng Wang, Yuqing Liang, Xiaoping Zeng, Enliang Li & Hongmei Wang. (2023) P53 together with ferroptosis: a promising strategy leaving cancer cells without escape. Acta Biochimica et Biophysica Sinica.
Crossref
Keit Men Wong, Eike Wegener, Alireza Baradaran-Heravi, Brenda Huppke, Jutta Gärtner & Peter Huppke. (2023) Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett Syndrome. International Journal of Molecular Sciences 24:14, pages 11665.
Crossref
Shan Li, Juan Li, Wenjing Shi, Ziyan Nie, Shasha Zhang, Fengdie Ma, Jun Hu, Jianjun Chen, Peiqiang Li & Xiaodong Xie. (2023) Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development. Biomolecules 13:6, pages 988.
Crossref
Iwona M. Pranke, Jessica Varilh, Aurélie Hatton, Caroline Faucon, Emmanuelle Girodon, Elise Dreano, Benoit Chevalier, Sabrina Karri, Philippe Reix, Isabelle Durieu, Laure Bidou, Olivier Namy, Magali Taulan, Alexandre Hinzpeter & Isabelle Sermet-Gaudelus. (2023) The U UGA C sequence provides a favorable context to ELX-02 induced CFTR readthrough. Journal of Cystic Fibrosis 22:3, pages 560-563.
Crossref
Sacha Spelier, Eveline P.M. van Doorn, Cornelis K. van der Ent, Jeffrey M. Beekman & Martijn A.J. Koppens. (2023) Readthrough compounds for nonsense mutations: bridging the translational gap. Trends in Molecular Medicine 29:4, pages 297-314.
Crossref
Martin R. Graf, Shruti Apte, Esteban Terzo, Simran Padhye, Shuhao Shi, Megan K. Cox, Roger B. Clark, Vijay Modur & Vasudeo Badarinarayana. (2023) Novel read through agent: ZKN-0013 demonstrates efficacy in APCmin model of familial adenomatous polyposis. Journal of Molecular Medicine 101:4, pages 375-385.
Crossref
Haolan Wang, Ming Guo, Hudie Wei & Yongheng Chen. (2023) Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Lekha E. Manjunath, Anumeha Singh, Saubhik Som & Sandeep M. Eswarappa. (2022) Mammalian proteome expansion by stop codon readthrough. WIREs RNA 14:2.
Crossref
Gazmend Temaj, Pelin Telkoparan-Akillilar, Nexhibe Nuhii, Silvia Chichiarelli, Sarmistha Saha & Luciano Saso. (2023) Recoding of Nonsense Mutation as a Pharmacological Strategy. Biomedicines 11:3, pages 659.
Crossref
Ori Hassin & Moshe Oren. (2022) Drugging p53 in cancer: one protein, many targets. Nature Reviews Drug Discovery 22:2, pages 127-144.
Crossref
Mikel D. Ghelfi, Saleem Y. Bhat, Hong Li & Barry S. Cooperman. (2023) A High-Throughput Assay for In Vitro Determination of Release Factor-Dependent Peptide Release from a Pretermination Complex by Fluorescence Anisotropy—Application to Nonsense Suppressor Screening and Mechanistic Studies. Biomolecules 13:2, pages 242.
Crossref
Shigeto Nishikawa & Tomoo Iwakuma. (2023) Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials. Cancers 15:2, pages 429.
Crossref
Mireia Palomar-Siles, Angelos Heldin, Meiqiongzi Zhang, Charlotte Strandgren, Viktor Yurevych, Jip T. van Dinter, Sem A. G. Engels, Damon A. Hofman, Susanne Öhlin, Birthe Meineke, Vladimir J. N. Bykov, Sebastiaan van Heesch & Klas G. Wiman. (2022) Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine. Cell Death & Disease 13:11.
Crossref
Laure Bidou, Olivier Bugaud, Goulven Merer, Matthieu Coupet, Isabelle Hatin, Egor Chirkin, Sabrina Karri, Stéphane Demais, Pauline François, Jean-Christophe Cintrat & Olivier Namy. (2022) 2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases. Proceedings of the National Academy of Sciences 119:35.
Crossref
Nina Schneider, Yogapriya Sundaresan, Prakadeeswari Gopalakrishnan, Avigail Beryozkin, Mor Hanany, Erez Y. Levanon, Eyal Banin, Shay Ben-Aroya & Dror Sharon. (2022) Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities. Progress in Retinal and Eye Research 89, pages 101029.
Crossref
Kohei Omachi, Hirofumi Kai, Michel Roberge & Jeffrey H. Miner. (2022) NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough. iScience 25:3, pages 103891.
Crossref
Michael J. Duffy, Naoise C. Synnott, Shane O’Grady & John Crown. (2022) Targeting p53 for the treatment of cancer. Seminars in Cancer Biology 79, pages 58-67.
Crossref
Silvia Lombardi, Maria Francesca Testa, Mirko Pinotti & Alessio Branchini. 2022. Disorders of Protein Synthesis. Disorders of Protein Synthesis 1 48 .
Luka A. Clarke, Vanessa C. C. Luz, Szymon Targowski, Sofia S. Ramalho, Carlos M. Farinha & Margarida D. Amaral. (2021) Integrity and Stability of PTC Bearing CFTR mRNA and Relevance to Future Modulator Therapies in Cystic Fibrosis. Genes 12:11, pages 1810.
Crossref
Gaspar Banfalvi. (2021) Janus-Faced Molecules against Plant Pathogenic Fungi. International Journal of Molecular Sciences 22:22, pages 12323.
Crossref
Charlène Valadon & Olivier Namy. (2021) The Importance of the Epi-Transcriptome in Translation Fidelity. Non-Coding RNA 7:3, pages 51.
Crossref
Lilas Alboushi, Angela P. Hackett, Parisa Naeli, Mostafa Bakhti & Seyed Mehdi Jafarnejad. (2021) Multifaceted control of mRNA translation machinery in cancer. Cellular Signalling 84, pages 110037.
Crossref
Mirco Schilff, Yelena Sargsyan, Julia Hofhuis & Sven Thoms. (2021) Stop Codon Context-Specific Induction of Translational Readthrough. Biomolecules 11:7, pages 1006.
Crossref
Patrícia Martins-Dias & Luísa Romão. (2021) Nonsense suppression therapies in human genetic diseases. Cellular and Molecular Life Sciences 78:10, pages 4677-4701.
Crossref
Sandra Luna, Leire Torices, Janire Mingo, Laura Amo, Isabel Rodríguez‐Escudero, Pablo Ruiz‐Ibarlucea, Asier Erramuzpe, Jesús M. Cortés, María I. Tejada, María Molina, Caroline E. Nunes‐Xavier, José I. López, Víctor J. Cid & Rafael Pulido. (2021) A global analysis of the reconstitution of PTEN function by translational readthrough of PTEN pathogenic premature termination codons . Human Mutation 42:5, pages 551-566.
Crossref
Alireza Baradaran-Heravi, Aruna D Balgi, Sara Hosseini-Farahabadi, Kunho Choi, Cristina Has & Michel Roberge. (2021) Effect of small molecule eRF3 degraders on premature termination codon readthrough. Nucleic Acids Research 49:7, pages 3692-3708.
Crossref
Rachida Amzal, Alice Thébaut, Martine Lapalus, Marion Almes, Brigitte Grosse, Elodie Mareux, Mauricette Collado‐Hilly, Anne Davit‐Spraul, Laure Bidou, Olivier Namy, Emmanuel Jacquemin & Emmanuel Gonzales. (2021) Pharmacological Premature Termination Codon Readthrough of ABCB11 in Bile Salt Export Pump Deficiency: An In Vitro Study. Hepatology 73:4, pages 1449-1463.
Crossref
Martin Y. Ng, Hong Li, Mikel D. GhelfiYale E. Goldman & Barry S. Cooperman. (2021) Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms. Proceedings of the National Academy of Sciences 118:2.
Crossref
Daniel R. McHugh, Calvin U. Cotton & Craig A. Hodges. (2020) Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations. International Journal of Molecular Sciences 22:1, pages 344.
Crossref
Silvia Lombardi, Maria Francesca Testa, Mirko Pinotti & Alessio Branchini. (2020) Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches. International Journal of Molecular Sciences 21:24, pages 9449.
Crossref
Daniel K. Crawford, Phillip Vanlandingham, Susan Schneider & Matthew M. Goddeeris. (2020) Intravitreal administration of small molecule read-through agents demonstrate functional activity in a nonsense mutation mouse model. Experimental Eye Research 201, pages 108274.
Crossref
Yun-Hsin Wang, Yau-Hung Chen & Wen-Hao Shen. (2020) Amikacin Suppresses Human Breast Cancer Cell MDA-MB-231 Migration and Invasion. Toxics 8:4, pages 108.
Crossref
S. E. Dmitriev, D. O. Vladimirov & K. A. Lashkevich. (2020) A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis. Biochemistry (Moscow) 85:11, pages 1389-1421.
Crossref
Jasiya Qadir, Sabhiya Majid, Mosin S. Khan, Fouzia Rashid, Mumtaz Din Wani, Inshah Din & Haamid Bashir. (2020) AT-rich Interaction Domain 1A Gene Variations: Genetic Associations and Susceptibility to Gastric Cancer Risk. Pathology & Oncology Research 26:4, pages 2237-2246.
Crossref
Daniel K. Crawford, Iris Alroy, Neal Sharpe, Matthew M. Goddeeris & Greg Williams. (2020) ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins. Journal of Pharmacology and Experimental Therapeutics 374:2, pages 264-272.
Crossref
Jyoti Sharma, Kim M. Keeling & Steven M. Rowe. (2020) Pharmacological approaches for targeting cystic fibrosis nonsense mutations. European Journal of Medicinal Chemistry 200, pages 112436.
Crossref
Natalia Mastrogamvraki & Apostolos Zaravinos. (2020) Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancer. npj Systems Biology and Applications 6:1.
Crossref
Gaspar Banfalvi. (2020) Antifungal Activity of Gentamicin B1 against Systemic Plant Mycoses. Molecules 25:10, pages 2401.
Crossref
Yeon Hee Ban, Myoung Chong Song, Je Won Park & Yeo Joon Yoon. (2020) Minor components of aminoglycosides: recent advances in their biosynthesis and therapeutic potential. Natural Product Reports 37:3, pages 301-311.
Crossref
Lisha Kuang, Kei Hashimoto, Eric J Huang, Matthew S Gentry & Haining Zhu. (2020) Frontotemporal dementia non-sense mutation of progranulin rescued by aminoglycosides. Human Molecular Genetics 29:4, pages 624-634.
Crossref
Revital Kariv, Michal Caspi, Naomi Fliss‐Isakov, Yamit Shorer, Yarden Shor, Guy Rosner, Eli Brazowski, Gil Beer, Shlomi Cohen & Rina Rosin‐Arbesfeld. (2019) Resorting the function of the colorectal cancer gatekeeper adenomatous polyposis coli. International Journal of Cancer 146:4, pages 1064-1074.
Crossref
Monica Borgatti, Emiliano Altamura, Francesca Salvatori, Elisabetta D’Aversa & Nicola Altamura. (2020) Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia. Journal of Clinical Medicine 9:2, pages 289.
Crossref
Amnon Wittenstein, Michal Caspi, Yifat David, Yamit Shorer, Prathamesh T. Nadar-Ponniah & Rina Rosin-Arbesfeld. (2019) Serum starvation enhances nonsense mutation readthrough. Journal of Molecular Medicine 97:12, pages 1695-1710.
Crossref
Ambra Campofelice, Laura Lentini, Aldo Di Leonardo, Raffaella Melfi, Marco Tutone, Andrea Pace & Ivana Pibiri. (2019) Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs). International Journal of Molecular Sciences 20:13, pages 3329.
Crossref
Michael W. Ferguson, Chloe A. N. Gerak, Christalle C. T. Chow, Ettore J. Rastelli, Kyle E. Elmore, Florian Stahl, Sara Hosseini-Farahabadi, Alireza Baradaran-Heravi, Don M. Coltart & Michel Roberge. (2019) The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418. PLOS ONE 14:5, pages e0216423.
Crossref
Safwat M. Rabea, Alireza Baradaran-Heravi, Aruna D. Balgi, Alexandra Krause, Sara Hosseini Farahabadi, Michel Roberge & David S. Grierson. (2019) 2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides. ACS Medicinal Chemistry Letters 10:5, pages 726-731.
Crossref
Emma J. Brasell, LeeLee Chu, Reyhan El Kares, Jung Hwa Seo, Robin Loesch, Diana M. Iglesias & Paul Goodyer. (2018) The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis. Pediatric Nephrology 34:5, pages 873-881.
Crossref
Emer P. Reeves, Danielle M. Dunlea, Karen McQuillan, Ciara A. O’Dwyer, Tomás P. Carroll, Radka Saldova, Prithvi Reddy Akepati, Mark R. Wormald, Oliver J. McElvaney, Vipatsorn Shutchaidat, Michael Henry, Paula Meleady, Joanne Keenan, Derek C. Liberti, Darrell N. Kotton, Pauline M. Rudd, Andrew A. Wilson & Noel G. McElvaney. (2019) Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity. The Journal of Immunology 202:8, pages 2240-2253.
Crossref
Warren P. Tate, Andrew G. Cridge & Chris M. Brown. (2018) ‘Stop’ in protein synthesis is modulated with exquisite subtlety by an extended RNA translation signal. Biochemical Society Transactions 46:6, pages 1615-1625.
Crossref
Martin Y. Ng, Haibo Zhang, Amy Weil, Vijay Singh, Ryan Jamiolkowski, Alireza Baradaran-Heravi, Michel Roberge, Allan Jacobson, Westley Friesen, Ellen Welch, Yale E. Goldman & Barry S. Cooperman. (2018) New in Vitro Assay Measuring Direct Interaction of Nonsense Suppressors with the Eukaryotic Protein Synthesis Machinery . ACS Medicinal Chemistry Letters 9:12, pages 1285-1291.
Crossref
Maciej Dabrowski, Zuzanna Bukowy-Bieryllo & Ewa Zietkiewicz. (2018) Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons. Molecular Medicine 24:1.
Crossref
Westley J. Friesen, Briana Johnson, Jairo Sierra, Jin Zhuo, Priya Vazirani, Xiaojiao Xue, Yuki Tomizawa, Ramil Baiazitov, Christie Morrill, Hongyu Ren, Suresh Babu, Young-Choon Moon, Art Branstrom, Anna Mollin, Jean Hedrick, Josephine Sheedy, Gary Elfring, Marla Weetall, Joseph M. Colacino, Ellen M. Welch & Stuart W. Peltz. (2018) The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential. PLOS ONE 13:10, pages e0206158.
Crossref
Virginie Marcel, Flora Nguyen Van Long & Jean-Jacques Diaz. (2018) 40 Years of Research Put p53 in Translation. Cancers 10:5, pages 152.
Crossref
Laure Bidou & Valérie Allamand. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 1 13 .
Sicong LiJunhong GuoAnna RevaFanglu HuangBinbin XiongYuanzhen LiuZixin Deng, Peter F. LeadlayYuhui Sun. (2018) Methyltransferases of gentamicin biosynthesis. Proceedings of the National Academy of Sciences 115:6, pages 1340-1345.
Crossref
Vladimir J. N. Bykov, Sofi E. Eriksson, Julie Bianchi & Klas G. Wiman. (2017) Targeting mutant p53 for efficient cancer therapy. Nature Reviews Cancer 18:2, pages 89-102.
Crossref
Akihiro Taguchi, Keisuke Hamada & Yoshio Hayashi. (2017) Chemotherapeutics overcoming nonsense mutation-associated genetic diseases: medicinal chemistry of negamycin. The Journal of Antibiotics 71:2, pages 205-214.
Crossref
Meiqiongzi Zhang, Angelos Heldin, Mireia Palomar-Siles, Susanne Öhlin, Vladimir J. N. Bykov & Klas G. Wiman. (2018) Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors. Frontiers in Oncology 7.
Crossref
Lisa Wiechers, Ananya Samanta & Kerstin Nagel-Wolfrum. (2017) Das Überlesen von Nonsense-MutationenRead-through of nonsense mutations. medizinische genetik 29:2, pages 217-224.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.